Bioactive and nuclease-resistant L-DNA ligand of vasopressin.
about
In vivo properties of an anti-GnRH Spiegelmer: an example of an oligonucleotide-based therapeutic substance class.Nucleic Acid aptamers: new methods for selection, stabilization, and application in biomedical scienceA two B-Z junction containing DNA resolves into an all right-handed double-helix.In vitro selection using a dual RNA library that allows primerless selectionFunctional nucleic acid sensorsShort bioactive Spiegelmers to migraine-associated calcitonin gene-related peptide rapidly identified by a novel approach: tailored-SELEXSpiegelmers: biostable aptamers.A Y2 receptor mimetic aptamer directed against neuropeptide Y.DNA ligands that bind tightly and selectively to cellobiose.A synthetic molecular system capable of mirror-image genetic replication and transcription.Mirror image DNA nanostructures for chiral supramolecular assemblies.Development of DNA aptamers using Cell-SELEX.Aptamers and the next generation of diagnostic reagents.Aptamer based surface enhanced Raman scattering detection of vasopressin using multilayer nanotube arrays.DNA aptamers as molecular probes for colorectal cancer study.Strategies for the discovery of therapeutic aptamers.Refilling drug delivery depots through the blood.An L-RNA-based aquaretic agent that inhibits vasopressin in vivo.Stereospecificity of oligonucleotide interactions revisited: no evidence for heterochiral hybridization and ribozyme/DNAzyme activityAptamers for pharmaceuticals and their application in environmental analytics.Aptamers: current challenges and future prospects.In vitro evolution of chemically-modified nucleic acid aptamers: Pros and cons, and comprehensive selection strategiesBiostable L-DNAzyme for Sensing of Metal Ions in Biological Systems.Binding of a structured D-RNA molecule by an L-RNA aptamer.Total chemical synthesis of a thermostable enzyme capable of polymerase chain reactionExploring the role of chirality in nucleic acid recognition.Aptamers as therapeutics in cardiovascular diseases.Characterisation of aptamers for therapeutic studies.Unraveling Prion Protein Interactions with Aptamers and Other PrP-Binding Nucleic Acids.Functional nucleic-acid-based sensors for environmental monitoring.Utilising the left-helical conformation of L-DNA for analysing different marker types on a single universal microarray platform.Biostable aptamers with antagonistic properties to the neuropeptide nociceptin/orphanin FQ.A DNA Spiegelmer to staphylococcal enterotoxin B.Aptamer and its applications in neurodegenerative diseases.Internal 32P-labeling of L-deoxyoligonucleotidesClinical applications of nucleic acid aptamers in cancer.Mirror-image polymerase chain reaction.Designing a Biostable L-DNAzyme for Lead(II) Ion Detection in Practical Samples.Rapid determination of enantiomeric ratio using fluorescent DNA or RNA aptamers.Colorimetric enantiorecognition of oligopeptide and logic gate construction based on DNA aptamer-ligand-gold nanoparticle interactions.
P2860
Q24530841-35433136-3489-4900-B5A1-5FE5C48D5C53Q26995510-A1952ECE-AA43-4D23-8B19-F3C454EA9648Q27628071-9E480550-4435-40BC-9D4E-5D0CE7B03F47Q29036552-0051069F-EEA1-462E-B087-5E8B2C28A6BCQ30481633-44D22F5B-B4C6-4050-AFF1-282A07A4A6ABQ30823550-A82B99AF-5CFC-487B-AF3E-0266D64512F5Q31005222-4F21FA06-7588-4E7B-81BE-FBC5D0724841Q31033093-C4FF0EA9-ED81-4836-9599-C215FBF262C3Q32064796-672259A3-BC76-42EA-BA46-3757ABC1B686Q33363386-EABDB80E-9713-4AFE-8298-108AF2DEA130Q33390740-EA28443F-4904-4A75-A6E2-B3B870A607F9Q33600982-2CBBA8D8-372E-4C4B-8796-32CFF4E6EF68Q33615065-63A64795-4391-4310-9F3B-DDEF2C0BDA86Q33637245-B4B67E4A-3521-4684-9F10-6E36A11EC661Q33775559-AC4E7846-F346-4001-8F99-765F1C34F7F1Q33831862-30BFA6B2-F01C-4B32-9AC0-DF0BCF6A0A94Q34144515-018C79B1-A95A-4BA8-89C4-408EDAB2212DQ34597041-4F20AC7F-6D10-4F9A-B3C8-20B9DD2509CFQ35560537-F641E486-3B4E-4988-B028-6D5A290BE04AQ35761658-1142C887-E10F-4375-9AF3-A428A96DA7F4Q35859041-F5E72A09-7B16-4E71-980C-8C68CC6E6783Q36156320-06911DE0-8AF5-4267-BEAF-689E4349C1A8Q36966466-379F1F6F-E1CA-4CF5-AC2D-2A5C90BB5C4EQ37245220-6186C8CB-B99C-4F77-951F-3F3259634C18Q37678647-B713AE63-F70B-46D6-AF55-E6325BE160A1Q37853120-AEA51184-E5C7-4305-B8CA-E87D75AB7BCCQ37919102-6D12E128-A0B1-4E55-83A3-72BBB529A808Q38089865-5E5CF243-A7FB-49E3-B261-221852C59228Q38288126-215D5DF7-7A5A-4E55-94CC-FB11E8ADF444Q38306542-94CEA3A3-E930-46FD-9D2A-63A41F9AF081Q38309363-4CB0A4CB-C542-4F82-A269-77CFE26DBFEAQ38344663-FE2D720B-CF07-41F8-9839-91BEE32C7117Q38353738-30CA68C3-1FF0-4F36-99C1-DE86FFD059F9Q38937721-1349651A-D0AB-4702-84CC-B6BB7C8081B5Q39744523-7C312E63-1969-4C40-8E36-D12956F7B640Q42332603-A2D2F12E-BA7D-49EC-9B52-80D409DBB545Q42379129-99AC9E26-6E62-4BD0-B6BD-61C8952A8572Q43048208-CA466142-1F44-486E-8C48-358AD96237A2Q43185000-82A34327-9B7B-435C-A975-ECB3CB68A3C1Q44579684-E1365FD6-A005-4C90-B140-C395A484CEF7
P2860
Bioactive and nuclease-resistant L-DNA ligand of vasopressin.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Bioactive and nuclease-resistant L-DNA ligand of vasopressin.
@ast
Bioactive and nuclease-resistant L-DNA ligand of vasopressin.
@en
type
label
Bioactive and nuclease-resistant L-DNA ligand of vasopressin.
@ast
Bioactive and nuclease-resistant L-DNA ligand of vasopressin.
@en
prefLabel
Bioactive and nuclease-resistant L-DNA ligand of vasopressin.
@ast
Bioactive and nuclease-resistant L-DNA ligand of vasopressin.
@en
P2093
P2860
P356
P1476
Bioactive and nuclease-resistant L-DNA ligand of vasopressin.
@en
P2093
D A Ausiello
D P Bartel
K P Williams
T N Schumacher
P2860
P304
11285-11290
P356
10.1073/PNAS.94.21.11285
P407
P577
1997-10-01T00:00:00Z